+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Single Nucleotide Polymorphism"

From
Molecular Breeding - Global Strategic Business Report - Product Thumbnail Image

Molecular Breeding - Global Strategic Business Report

  • Report
  • April 2024
  • 88 Pages
  • Global
From
Personalized Medicines: Global Strategic Business Report - Product Thumbnail Image

Personalized Medicines: Global Strategic Business Report

  • Report
  • April 2024
  • 216 Pages
  • Global
From
From
From
Genotyping Assay Global Market Report 2024 - Product Thumbnail Image

Genotyping Assay Global Market Report 2024

  • Report
  • March 2024
  • 175 Pages
  • Global
From
Direct-to-Consumer (DTC) Genetic Testing Global Market Report 2024 - Product Thumbnail Image

Direct-to-Consumer (DTC) Genetic Testing Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Genotyping Global Market Report 2024 - Product Thumbnail Image

Genotyping Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Molecular Breeding Global Market Report 2024 - Product Thumbnail Image

Molecular Breeding Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
Loading Indicator

Single Nucleotide Polymorphism (SNP) is a type of genetic variation that occurs when a single nucleotide in the genome sequence is altered. SNPs are the most common type of genetic variation among individuals and are used in genomics to identify genetic differences between individuals. SNP analysis is used to identify genetic markers associated with diseases, to study the genetic basis of complex traits, and to identify genetic variants associated with drug response. SNP analysis is used in a variety of applications, including personalized medicine, pharmacogenomics, and population genetics. SNP analysis is also used in the development of diagnostic tests, drug discovery, and gene therapy. SNP analysis is also used in the development of genetic tests for disease risk assessment and in the development of genetic tests for disease diagnosis. The SNP market is a rapidly growing market, driven by the increasing demand for personalized medicine and the development of new technologies for SNP analysis. Companies in the SNP market include Illumina, Thermo Fisher Scientific, BGI, and Genomics plc. Show Less Read more